Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple MyelomaYukiko Cho, Mitsuo Hori, Yasushi Okoshi et al.|Acta Haematologica|2015Cited by 1